NEKTAR THERAPEUTICS (NKTR) Forecast, Price Target & Analyst Ratings

NASDAQ:NKTR • US6402683063

Current stock price

76.99 USD
+1.28 (+1.69%)
At close:
77.2 USD
+0.21 (+0.27%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEKTAR THERAPEUTICS (NKTR).

Forecast Snapshot

Consensus Price Target

Price Target
$139.16
+ 80.75% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$1.76
Revenue Estimate
10.91M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.25%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$139.16
Upside
+ 80.75%
From current price of $76.99 to mean target of $139.16, Based on 16 analyst forecasts
Low
$106.05
Median
$142.80
High
$173.25

Price Target Revisions

1 Month
5.06%
3 Months
19.23%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for NKTR. The average price target is 139.16 USD. This implies a price increase of 80.75% is expected in the next year compared to the current price of 76.99.
The average price target has been revised upward by 19.23% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NKTR Current Analyst RatingNKTR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

NKTR Historical Analyst RatingsNKTR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
86.25%
NKTR was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NKTR.
In the previous month the buy percentage consensus was at a similar level.
NKTR was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-24WedbushInitiate Neutral
2026-03-17TD CowenInitiate Buy
2026-03-16CitigroupMaintains Buy -> Buy
2026-02-23B. Riley SecuritiesReiterate Buy -> Buy
2026-02-10BTIGMaintains Buy -> Buy
2026-02-10HC Wainwright & Co.Maintains Buy -> Buy
2026-01-29BTIGReiterate Buy -> Buy
2025-12-16BTIGMaintains Buy -> Buy
2025-12-16HC Wainwright & Co.Maintains Buy -> Buy
2025-11-26CitigroupInitiate Buy
2025-11-26JefferiesMaintains Buy -> Buy
2025-09-23B. Riley SecuritiesMaintains Buy -> Buy
2025-09-19BTIGReiterate Buy -> Buy
2025-07-08B. Riley SecuritiesMaintains Buy -> Buy
2025-06-24HC Wainwright & Co.Maintains Buy -> Buy
2025-04-11JefferiesUpgrade Hold -> Buy
2025-03-14OppenheimerUpgrade Perform -> Outperform
2025-03-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-08B. Riley SecuritiesInitiate Buy
2024-11-04Piper SandlerInitiate Overweight
2024-03-06JefferiesMaintains Hold -> Hold
2023-11-20JP MorganReiterate Underweight
2023-11-09TD CowenUpgrade Market Perform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$1.76
Revenue Estimate
10.91M
Revenue Q2Q
4.44%
EPS Q2Q
50.97%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
3.97%
Revenue (3 Months)
1.11%
EPS (1 Month)
15.52%
EPS (3 Months)
19.51%

Next Earnings Summary

NKTR is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -1.76 USD and the consensus revenue estimate is 10.91M USD.
The next earnings revenue estimate has been revised upward by 1.11% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NKTR revenue by date.NKTR revenue by date.
90.122M
-2.15%		98.427M
9.22%		55.232M
-43.89%		42.198M
-23.60%		36.638M
-13.18%		47.707M
30.21%		98.99M
107.50%		297.32M
200.35%		513.02M
72.55%		787.42M
53.49%		1.169B
48.46%
EBITDA
YoY % growth
NKTR ebitda by date.NKTR ebitda by date.
-127.41M
43.95%		-125.527M
1.48%		-129.745M
-3.36%		-218.591M
-68.48%		-345.834M
-58.21%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
NKTR ebit by date.NKTR ebit by date.
-135.225M
43.73%		-129.918M
3.92%		-130.771M
-0.66%		-234.622M
-79.41%		-340.223M
-45.01%		-388.698M
-14.25%		-375.304M
3.45%		-291.744M
22.26%		7.739M
102.65%		257.19M
3,223.30%		520.8M
102.50%
Operating Margin
NKTR operating margin by date.NKTR operating margin by date.
-150.05%-131.99%-236.77%-556.00%-928.61%-814.76%-379.13%-98.12%1.51%32.66%44.55%
EPS
YoY % growth
NKTR eps by date.NKTR eps by date.
-15.75
46.70%		-11.70
25.71%		-10.20
12.82%		-9.81
3.78%		-12.04
-22.66%		-13.14
-9.14%		-10.47
20.34%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-1.76
50.97%		-2.06
30.16%		-1.96
-4.80%		-2.87
-61.00%		-3.03
-71.45%		-3.05
-48.20%		-3.09
-57.53%		-3.10
-8.32%		-3.39
-11.91%		-3.36
-9.91%		-3.18
-3.08%		-2.98
4.05%
Revenue
Q2Q % growth		10.91M
4.44%		10.662M
-4.59%		10.33M
-12.38%		10.366M
-52.46%		10.997M
0.80%		10.958M
2.78%		10.924M
5.75%		10.887M
5.03%		10.71M
-2.61%		10.71M
-2.26%		10.71M
-1.96%		10.71M
-1.63%
EBITDA
Q2Q % growth		-39.26M
10.65%		-51.567M
-46.74%		-68.096M
-121.84%		-89.315M
-394.44%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-40.917M
7.77%		-51.518M
-43.97%		-38.612M
-22.45%		-73.867M
-286.94%		-80.109M
-95.78%		-83.049M
-61.20%		-86.169M
-123.17%		-89.372M
-20.99%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NKTR Yearly Revenue VS EstimatesNKTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
NKTR Yearly EPS VS EstimatesNKTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 20 -20 40 -40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-8.80%
EPS Next 5 Year
-0.64%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
2.23%
Revenue Next 5 Year
46.10%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NEKTAR THERAPEUTICS / NKTR Forecast FAQ

Can you provide the average price target for NEKTAR THERAPEUTICS stock?

16 analysts have analysed NKTR and the average price target is 139.16 USD. This implies a price increase of 80.75% is expected in the next year compared to the current price of 76.99.

What is the next earnings date for NKTR stock?

NEKTAR THERAPEUTICS (NKTR) will report earnings on 2026-05-06, after the market close.

What are the consensus estimates for NEKTAR THERAPEUTICS (NKTR) next earnings?

The consensus EPS estimate for the next earnings of NEKTAR THERAPEUTICS (NKTR) is -1.76 USD and the consensus revenue estimate is 10.91M USD.

How do analysts rate NEKTAR THERAPEUTICS (NKTR)?

The consensus rating for NEKTAR THERAPEUTICS (NKTR) is 86.25 / 100 . This indicates that analysts generally have a positive outlook on the stock.